US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

prospan, Diprolene, Diprosone, Diprolene AF, Betamethasone Dipropionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 8 EU WC, 2 KDMF, 10 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers, 79 FDA Orange Book, 7 Europe, 3 Canada, 24 Australia, 9 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Actylis, 1 Alcedo Pharmachem, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 1 Kerry, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

27 Topical, 13 Film Formers & Plasticizers, 9 Emulsifying Agents, 8 Parenteral, 8 Solubilizers, 6 Lubricants & Glidants, 6 Thickeners and Stabilizers, 5 Fillers, Diluents & Binders, 5 Coating Systems & Additives, 4 Controlled & Modified Release, 4 Taste Masking, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 2 Granulation, 1 Rheology Modifiers, 1 Co-Processed Excipients, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 17 Finished Drug Prices, 9 Annual Reports

MARKET PLACE

18 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents

20 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 5 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	Curia	U.S.A	Curia Spain S. A. U.	219MF10367	Betamethasone dipropionate (JP)	2007-12-13	2017-12-08	Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain
26/09/2024	MSD INTL GMBH	Singapore	MSD International GmbH (Singapore Branch)	218MF10865	Betamethasone dipropionate	2006-11-06	2014-03-13	50 Tuas West Drive Singapore 638408

List of Drug Master Files (JDMF) for prospan, Diprolene, Diprosone, Diprolene AF, Betamethasone Dipropionate Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Prospan, Diprolene, Diprosone, Diprolene AF, Betamethasone Dipropionate

prospan, Diprolene, Diprosone, Diprolene AF, Betamethasone Dipropionate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

8 EU WC

2 KDMF

10 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers

79 FDA Orange Book

7 Europe

3 Canada

24 Australia

9 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

3 DKSH

1 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Actylis

1 Alcedo Pharmachem

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

1 Kerry

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

27 Topical

13 Film Formers & Plasticizers

9 Emulsifying Agents

8 Parenteral

8 Solubilizers

6 Lubricants & Glidants

6 Thickeners and Stabilizers

5 Fillers, Diluents & Binders

5 Coating Systems & Additives

4 Controlled & Modified Release

4 Taste Masking

3 Direct Compression

3 Surfactant & Foaming Agents

2 Chewable & Orodispersible Aids

2 Granulation

1 Rheology Modifiers

1 Co-Processed Excipients

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons